Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-09-18

Clinical Trial Update: Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating chemotherapy with or without bevacizumab in surgically removable stage I–IIIA breast cancer; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bevacizumab (bevacizumab)

Snippet

Sponsor: NSABP Foundation Inc | Conditions: Breast Cancer | Phase 3 | Status: UNKNOWN | Results posted: 2017-09-18